Hemogenyx Pharmaceuticals plc
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located at its state-of-the-art research facility in New York City and a Belgian subsidiary, Hemogenyx-Cell SPRL, located in Liege. We are focused on bringing our cell therapy and immunotherapies to patients in need.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Research
- Market Focus:
- Internationally (various countries)
About Us
For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from blood diseases. The risks of toxicity and death that are associated with bone marrow transplantation, however, have meant that the procedure is restricted to use only as a last resort. Hemogenyx Pharmaceuticals plc’s technology has the potential to enable many more patients suffering from devastating blood diseases such as leukemia and lymphoma, as well as severe autoimmune diseases such as multiple sclerosis, aplastic anemia and systemic lupus erythematosus (Lupus), to benefit from bone marrow transplantation.
Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. The Company is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
Our passionate mission
We believe that we can transform patients’ lives by delivering breakthrough therapies. We also believe that good business means healthy people and a better world.
DEVELOP
To develop new therapies that are based on breakthrough science
HOPE
To bring hope to patients with serious or life threatening diseases
TREAT
To treat life threatening diseases, bringing societal benefit
VALUE
To realize unique treatment opportunities for patients and value for investors
Our core values are Integrity, Courage and Ingenui...
Integrity means that we are open, honest and genuine. Courage means that we are entrepreneurial, take calculated risks and strive to reach beyond the boundaries of accepted theories. Ingenuity means that we discover, invent and use our discoveries for the benefit of the patients.